Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Pulmonary Hypertension

  Free Subscription


14.09.2026

1 Am J Physiol Heart Circ Physiol
1 Ann Med
1 Antiinflamm Antiallergy Agents Med Chem
1 Biochem Pharmacol
1 Cardiovasc Interv Ther
1 Case Rep Perinat Med
1 Chest
2 Circ Heart Fail
1 Circ Res
1 Clin Case Rep
1 Clinics (Sao Paulo)
1 Curr Opin Pulm Med
1 Curr Rheumatol Rev
1 Drug Des Devel Ther
1 Ecotoxicol Environ Saf
1 Eur Heart J
1 Eur Heart J Imaging Methods Pract
3 Eur Respir J
1 Exp Lung Res
1 Int J Chron Obstruct Pulmon Dis
1 Int J Clin Pharm
1 Int J Nanomedicine
1 Int J Obstet Anesth
1 J Cardiol Cases
1 J Coll Physicians Surg Pak
1 J Perinatol
1 J Psychosom Res
1 J Racial Ethn Health Disparities
1 J Vet Cardiol
1 JACC Case Rep
1 JHLT Open
1 Kardiol Pol
1 Kyobu Geka
1 Minerva Med
1 Pediatr Res
1 Phytomedicine
6 Pulm Circ
1 Quant Imaging Med Surg
1 Rheumatology (Oxford)
1 Semin Arthritis Rheum
1 Surg Today
1 TH Open
1 Zhonghua Jie He He Hu Xi Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Physiol Heart Circ Physiol

  1. JAMES KS, Helms MN
    Unraveling the NO-sGC-cGMP Pathway in BPD-Associated Pulmonary Hypertension.
    Am J Physiol Heart Circ Physiol. 2026 Sep 8. doi: 10.1152/ajpheart.90017.2026.
    PubMed        


    Ann Med

  2. WANG Q, Hao L, Cao W, Hu C, et al
    Burden dynamics of pulmonary arterial hypertension in China and the G20 aggregate: a comparative analysis based on the global burden of disease study 2023.
    Ann Med. 2026;58:2727194.
    PubMed         Abstract available


    Antiinflamm Antiallergy Agents Med Chem

  3. TSUCHIDA K
    Clinical Applications of Ligand Traps Targeting Activin Type II Receptors.
    Antiinflamm Antiallergy Agents Med Chem. 2026;25:73-78.
    PubMed         Abstract available


    Biochem Pharmacol

  4. XIE Y, Li J, Liao J, Meng H, et al
    beta-Sitosterol attenuates pulmonary arterial hypertension by activating the Nrf2-GPX4 axis to inhibit ferroptosis in pulmonary vascular cells.
    Biochem Pharmacol. 2026;253.
    PubMed         Abstract available


    Cardiovasc Interv Ther

  5. GATUZ MV, Okuno T, Tanaka T, Kai T, et al
    Phenotypes, periprocedural hemodynamic changes, and impact of pulmonary hypertension in patients undergoing mitral transcatheter edge-to-edge repair.
    Cardiovasc Interv Ther. 2026 Sep 9. doi: 10.1007/s12928-026-01346.
    PubMed         Abstract available


    Case Rep Perinat Med

  6. FOULI GE, Subba-Rao R, Bhat R, Greenough A, et al
    An infant with persistent pulmonary hypertension of the newborn and congenital hypothyroidism.
    Case Rep Perinat Med. 2026;15:20260003.
    PubMed         Abstract available


    Chest

  7. WESSELS JN, Celant LR
    Brain Natriuretic Peptide-Guided Risk Stratification in Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Endarterectomy: A Foundation for Multimodal Assessment.
    Chest. 2026;170:657-658.
    PubMed        


    Circ Heart Fail

  8. GARRY JD, Brittain EL
    Disentangling Pulmonary Vascular Phenotypes in Group 2 Pulmonary Hypertension Using Bioactive Lipid Profiling.
    Circ Heart Fail. 2026 Sep 10:e014894. doi: 10.1161/CIRCHEARTFAILURE.126.014894.
    PubMed        

  9. ALOTAIBI M, Tang A, Sun N, Gurholt I, et al
    Fatty Acid and Oxylipin Metabolism Differentiate Isolated Postcapillary From Combined Pre- and Postcapillary Pulmonary Hypertension.
    Circ Heart Fail. 2026 Sep 10:e014073. doi: 10.1161/CIRCHEARTFAILURE.125.014073.
    PubMed         Abstract available


    Circ Res

  10. KOGAMI M, Kato Y, Ito S, Uchida K, et al
    Mechanosensitive Stanniocalcin-1 Suppresses Pulmonary Artery Smooth Muscle Cell Proliferation and Attenuates Experimental Pulmonary Hypertension.
    Circ Res. 2026 Sep 9. doi: 10.1161/CIRCRESAHA.125.327869.
    PubMed         Abstract available


    Clin Case Rep

  11. ASHRAF B, Hussain MU, Zahid A, Sohail F, et al
    Transition From Pulmonary to Gastrointestinal Hemorrhage: A Rare Case of Hematemesis in an Adolescent With Chronic Pulmonary Hypertension and Valvular Regurgitation.
    Clin Case Rep. 2026;14:e73480.
    PubMed         Abstract available


    Clinics (Sao Paulo)

  12. PINTO S, Salvi de Souza G, Jeckel CMM, Bodanese LC, et al
    Role of PET imaging in evaluating right ventricular function and prognosis in pulmonary hypertension.
    Clinics (Sao Paulo). 2026;81:101101.
    PubMed         Abstract available


    Curr Opin Pulm Med

  13. LACAVERA M, Asghar A, Ballard J, Bandla M, et al
    Pulmonary hypertension related to sleep-disordered breathing.
    Curr Opin Pulm Med. 2026 Sep 9. doi: 10.1097/MCP.0000000000001307.
    PubMed         Abstract available


    Curr Rheumatol Rev

  14. ILLAHI D, Parrey AH, Ismail M
    Prevalence, Severity, and Pattern of Pulmonary Arterial Hypertension and Interstitial Lung Disease in Patients with Connective Tissue Disease.
    Curr Rheumatol Rev. 2026;22:e15733971388491.
    PubMed         Abstract available


    Drug Des Devel Ther

  15. LIN Y, Han J, Liu G, Cheng K, et al
    Integrated Metabolomic and Transcriptomic Analysis Suggests Potential Therapeutic Mechanism of Shengxian Decoction in Hypobaric Hypoxia-Induced Pulmonary Hypertension in SD Rats.
    Drug Des Devel Ther. 2026;20:603123.
    PubMed         Abstract available


    Ecotoxicol Environ Saf

  16. KUANG L, Huang EL, Zhang BY, Chen HJ, et al
    Long-term ambient air pollution exposure, metabolomic signatures, and incident pulmonary hypertension: A large prospective cohort study.
    Ecotoxicol Environ Saf. 2026;323:120778.
    PubMed         Abstract available


    Eur Heart J

  17. NAMAJIMA T, Ushijima R, Tanaka R
    Novel oblique dynamic chest radiography for retrocardiac pulmonary blood flow imaging in chronic thromboembolic pulmonary hypertension.
    Eur Heart J. 2026 Sep 7:ehag711. doi: 10.1093.
    PubMed        


    Eur Heart J Imaging Methods Pract

  18. ALNASSER TN, Hokmabadi A, Maiter A, Sharkey M, et al
    AI-based pulmonary artery to ascending aorta ratio on non-contrast CT for pulmonary hypertension: diameter vs. volume assessment.
    Eur Heart J Imaging Methods Pract. 2026;4:qyag146.
    PubMed         Abstract available


    Eur Respir J

  19. GRYNBLAT J, Coulet F, Lacoste-Palasset T, Jais X, et al
    Beyond Heritable PAH: Pulmonary Hypertension in Genetic Syndromes.
    Eur Respir J. 2026 Sep 10:2600808. doi: 10.1183/13993003.00808-2026.
    PubMed         Abstract available

  20. GHANI H, Pepke-Zaba J
    Reverse remodelling in chronic thromboembolic pulmonary hypertension: the right ventricular enigma continues.
    Eur Respir J. 2026;68:2601039.
    PubMed        

  21. AERTS G, Willems L, Tielemans B, Muscogiuri E, et al
    Three-dimensional micro-CT analysis of vascular remodelling and vascular pruning in pulmonary arterial hypertension.
    Eur Respir J. 2026;68:2502118.
    PubMed         Abstract available


    Exp Lung Res

  22. PU M
    Correlation between ACE2 and monocrotaline-induced pulmonary arterial hypertension in rats.
    Exp Lung Res. 2026;52:182-195.
    PubMed         Abstract available


    Int J Chron Obstruct Pulmon Dis

  23. DONG F, Tanaka Y, Okamura K, Higa K, et al
    Right Ventricular Isovolumetric Relaxation Time is Associated with Pulmonary Vascular Load and Functional Limitation in Chronic Obstructive Pulmonary Disease.
    Int J Chron Obstruct Pulmon Dis. 2026;21:628505.
    PubMed         Abstract available


    Int J Clin Pharm

  24. CAO Z, Meng L, Li Y, Zhou M, et al
    Comparative clinical evaluation of endothelin receptor antagonists in pulmonary arterial hypertension using a multi-criteria decision analysis framework.
    Int J Clin Pharm. 2026;48:1947-1956.
    PubMed         Abstract available


    Int J Nanomedicine

  25. SONG S, Wu J, Yin M, Shi Y, et al
    Targeting Inflammation-Oxidative Stress Crosstalk: Advances and Challenges in Nanocarrier-Based Interventional Strategies for Pulmonary Arterial Hypertension.
    Int J Nanomedicine. 2026;21:620348.
    PubMed         Abstract available


    Int J Obstet Anesth

  26. WORKU E, Pittard M, Duffin S, Carey R, et al
    Awake venoarterial extracorporeal membrane oxygenation as a bridge to foetal maturation in severe pulmonary hypertension: a case report.
    Int J Obstet Anesth. 2026;68:105278.
    PubMed         Abstract available


    J Cardiol Cases

  27. MOMOI M, Anzai A, Maeda T, Ikegami S, et al
    Progression of chronic thromboembolic pulmonary disease without pulmonary hypertension in a case with JAK2 V617F mutation.
    J Cardiol Cases. 2026;34:133-136.
    PubMed         Abstract available


    J Coll Physicians Surg Pak

  28. KIZILOGLU HA, Yakar HI
    Combined Pulmonary Fibrosis and Emphysema: Clinicoradiological Parameters Associated with Fibrosis Patterns.
    J Coll Physicians Surg Pak. 2026;36:1120-1125.
    PubMed         Abstract available


    J Perinatol

  29. DADON Y, Mimouni FB, Arad I, Mendlovic J, et al
    Magnesium therapy in persistent pulmonary hypertension of the newborn: a scoping review.
    J Perinatol. 2026 Sep 10. doi: 10.1038/s41372-026-02893.
    PubMed         Abstract available


    J Psychosom Res

  30. WANG X, Qiu F, Li S, Li S, et al
    Cross-sectional independent associations of anxiety and depressive symptoms with cardiopulmonary exercise performance in treatment-naive chronic thromboembolic pulmonary hypertension.
    J Psychosom Res. 2026;211:112993.
    PubMed         Abstract available


    J Racial Ethn Health Disparities

  31. FARBER HW, Chakinala MM, Hemnes AR, Chin KM, et al
    Characteristics of Patients with Pulmonary Arterial Hypertension Receiving Selexipag in the SPHERE Registry by Race and Ethnicity.
    J Racial Ethn Health Disparities. 2026;13:4283-4295.
    PubMed         Abstract available


    J Vet Cardiol

  32. NEMANIC TS, Fabella A
    Use of ambrisentan in the management of refractory pulmonary arterial hypertension following occlusion of a bidirectionally shunting patent ductus arteriosus in a dog.
    J Vet Cardiol. 2026;66:56-62.
    PubMed         Abstract available


    JACC Case Rep

  33. ALLAM H, Fredman E, Kobayashi D, Aggarwal M, et al
    Transcatheter Sinus Venosus ASD Closure in Severe Pulmonary Hypertension.
    JACC Case Rep. 2026 Sep 1:110220. doi: 10.1016/j.jaccas.2026.110220.
    PubMed         Abstract available


    JHLT Open

  34. RAVNESTAD H, Ahmed S, Ostby CM, Gude E, et al
    The association between soluble ST2 and transplant-free survival in precapillary pulmonary hypertension.
    JHLT Open. 2026;14:100661.
    PubMed         Abstract available


    Kardiol Pol

  35. WALIGORA M, Kurzyna M, Mularek-Kubzdela T, Skoczylas I, et al
    Early and long-term outcomes and their predictors in incident pulmonary arterial hypertension: Results from the Database of Pulmonary Hypertension in Poland (BNP-PL).
    Kardiol Pol. 2026 Sep 8. doi: 10.33963/v.phj.114700.
    PubMed         Abstract available


    Kyobu Geka

  36. TSUGE S, Takaki J, Yoshinaga T, Fukui T, et al
    [Post-cardiac Surgery Pulmonary Hypertension Improved by High-flow Arteriovenous Shunts Closure].
    Kyobu Geka. 2026;79:407-410.
    PubMed         Abstract available


    Minerva Med

  37. BANDYOPADHYAY D, Smith JE, Asif H, Uysal A, et al
    Pulmonary hypertension in interstitial lung disease: today's realities, tomorrow's possibilities.
    Minerva Med. 2026 Sep 10. doi: 10.23736/S0026-4806.26.09859.
    PubMed         Abstract available


    Pediatr Res

  38. ALTIT G, Sant'Anna G
    Artificial intelligence in neonatal hemodynamics: toward earlier and more reliable detection of pulmonary hypertension.
    Pediatr Res. 2026 Sep 11. doi: 10.1038/s41390-026-05461.
    PubMed        


    Phytomedicine

  39. DONG Z, Lu Q, Xue Z, Li Y, et al
    Sodium tanshinone IIA sulfonate attenuates pulmonary vascular remodeling by targeting DYRK1A in pulmonary hypertension.
    Phytomedicine. 2026;162:158794.
    PubMed         Abstract available


    Pulm Circ

  40. YAMASHITA J, Ito R, Ikeda S, Hasegawa K, et al
    Invasive Management for Acute-on-Chronic Thromboembolic Pulmonary Hypertension: Feasibility and Clinical Outcomes in a Single-Center Cohort.
    Pulm Circ. 2026;16:e70407.
    PubMed         Abstract available

  41. HERNANDEZ NV, Maestre MJ, Chavarria M, Munnangi P, et al
    Referral Patterns and Clinical Characteristics of Patients With Pulmonary Hypertension at a Comprehensive Care Center.
    Pulm Circ. 2026;16:e70399.
    PubMed         Abstract available

  42. MUNCHEL JK, Flashner BM, Imai R, Kholdani CA, et al
    Beyond IPF: Pulmonary Function Test Predictors of Echocardiographic Pulmonary Hypertension Across the Spectrum of ILD.
    Pulm Circ. 2026;16:e70400.
    PubMed         Abstract available

  43. HALL MM, Rinne ST, Elwy AR, Wiener RS, et al
    Quality of Pulmonary Hypertension Care Within Expert PH Centers: Patient and Provider Perspectives From a Multi-Site Qualitative Study.
    Pulm Circ. 2026;16:e70408.
    PubMed         Abstract available

  44. CHEN R, Bagherzadeh SP, Patel N, Khoury P, et al
    Validation of Tricuspid Annular Displacement by Tissue Doppler in Pulmonary Hypertension.
    Pulm Circ. 2026;16:e70372.
    PubMed         Abstract available

  45. BEKIARIDOU A, Mughrabi I, Rios N, Giannakoulas G, et al
    Splenic Focused Ultrasound Improves Experimental Pulmonary Hypertension and Reprograms Immune Responses in Female and Male Rats.
    Pulm Circ. 2026;16:e70392.
    PubMed         Abstract available


    Quant Imaging Med Surg

  46. LYU Y, Tian L, Dai D, Xiang P, et al
    Diagnostic performance of the main pulmonary artery-to-ascending aorta diameter ratio for pulmonary hypertension defined by mean pulmonary arterial pressure in children with left-to-right shunt congenital heart disease.
    Quant Imaging Med Surg. 2026;16:735.
    PubMed         Abstract available


    Rheumatology (Oxford)

  47. RAGHUPATHY J, Teoh WS, Kanneganti A, Binte Abdul Kadir H, et al
    Clinical and autoantibody associations with malignancy in systemic sclerosis: a systematic review and meta-analysis.
    Rheumatology (Oxford). 2026;65:keag356.
    PubMed         Abstract available


    Semin Arthritis Rheum

  48. HAUSSMANN AJ, Chin AT, Wilhalme H, Volkmann ER, et al
    Interstitial lung disease in mixed connective tissue disease: Insights from an electronic health record-based retrospective cohort study.
    Semin Arthritis Rheum. 2026;80:153043.
    PubMed         Abstract available


    Surg Today

  49. YOSHINO I, Saji H, Suzuki H
    The lung-muscle metabolic axis: a proposed mechanism for post-resection systemic frailty.
    Surg Today. 2026;56:2111-2117.
    PubMed         Abstract available


    TH Open

  50. RODENBURG TC, Hoek LJO, Kan CV, Aman J, et al
    Antiphospholipid Syndrome in Chronic Thromboembolic Pulmonary Hypertension and Chronic Thromboembolic Pulmonary Disease without Pulmonary Hypertension: Prevalence and Clinical Impact in a Dutch Cohort.
    TH Open. 2026;10:a29386324.
    PubMed         Abstract available


    Zhonghua Jie He He Hu Xi Za Zhi


  51. [Chinese expert consensus on a standardized echocardiography procedure and right heart evaluation for pulmonary thromboembolism (2026 edition)].
    Zhonghua Jie He He Hu Xi Za Zhi. 2026;49:957-970.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum